| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |